Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.
about
Exploring the effect of substituent in the hydrazone ligand of a family of μ-oxidodivanadium(v) hydrazone complexes on structure, DNA binding and anticancer activity.Exploring the effect of hydroxylic and non-hydroxylic solvents on the reaction of [VIVO(β-diketonate)2] with 2-aminobenzoylhydrazide in aerobic and anaerobic conditions.Vanadium Compounds as PTP Inhibitors.VIVO complexes with antibacterial quinolone ligands and their interaction with serum proteins.
P2860
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.
@en
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.
@nl
type
label
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.
@en
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.
@nl
prefLabel
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.
@en
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.
@nl
P2093
P2860
P356
P1433
P1476
Speciation in human blood of Metvan, a vanadium based potential anti-tumor drug.
@en
P2093
Giovanni Micera
Linda Bíró
Péter Buglyó
Valeria Ugone
P2860
P304
P356
10.1039/C7DT00943G
P407
P577
2017-06-22T00:00:00Z